Stay updated on Benralizumab in HES: Efficacy and Safety Clinical Trial
Sign up to get notified when there's something new on the Benralizumab in HES: Efficacy and Safety Clinical Trial page.

Latest updates to the Benralizumab in HES: Efficacy and Safety Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedResults posted status added and locations expanded to 52 (including Shanghai, China); the page now shows additional DB-period endpoints and data descriptions, reflecting the updated results dataset.SummaryDifference3%

- Check21 days agoChange DetectedPublications section updated to show the final Nat Med citation for the NATRON study with Jun 2026 publication details and full DOI, replacing the previous online-ahead-of-print entry. This clarifies attribution and the publication status of the study in the Publications section.SummaryDifference0.0%

- Check28 days agoChange DetectedThe page revision was updated from v3.6.0 to v3.6.3, signaling a newer version of the page. It appears to be a minor administrative update with no changes to trial data or study details.SummaryDifference0.0%

- Check42 days agoChange DetectedDifference0.3%

- Check49 days agoChange DetectedRevision label updated from v3.5.4 to v3.5.5 in the page footer, signaling a minor software/template update. No clinical trial data or study details are altered.SummaryDifference0.0%

- Check71 days agoChange DetectedThe page's revision label was updated from v3.5.3 to v3.5.4, indicating a version bump of the page or site rendering. There are no changes to the study details or substantive content.SummaryDifference0.0%

Stay in the know with updates to Benralizumab in HES: Efficacy and Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Benralizumab in HES: Efficacy and Safety Clinical Trial page.